Geneva Life Holdings Completes Acquisition of Geneva International Insurance
The
GII has served policyholders since 2016. Over the past decade, GII built what is difficult to replicate: differentiated insurance know-how, mature policy operations, and standing relationships with regulators and counterparties, together with the legal and tax architecture that private placement structures require. The acquisition preserves that foundation in full: GII's licenses, regulatory standing, management, and policy administration continue without interruption, and in-force policies remain administered under their existing terms.
"
"Nothing changes for policyholders, and that is the point," said
To learn more about
About Geneva Life Holdings
Geneva Life Holdings, LLC is an independently owned financial services holding company established in 2026 and headquartered in
About Geneva International Insurance
Geneva International Insurance Inc. is a life insurance company licensed and regulated by the Financial Services Commission of Barbados, with an election under Section 953(d) of the U.S. Internal Revenue Code to be treated as a U.S. taxpayer. Since 2016, GII has provided private placement life insurance and private placement variable annuity solutions to eligible individuals, families, and institutions. Learn more at geneva-ppli.com
This press release is provided for general informational purposes only. Nothing herein constitutes an offer to sell, or a solicitation of an offer to buy, any security, insurance product, or other financial instrument, nor does it constitute investment, legal, or tax advice. Products and services referenced are available only to eligible persons in jurisdictions where they may lawfully be offered.
View original content to download multimedia:https://www.prnewswire.com/news-releases/geneva-life-holdings-completes-acquisition-of-geneva-international-insurance-302835560.html
SOURCE Geneva Life Holdings
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mini PC Brand VZMORE Makes Global Debut at ShowStoppers @ IFA 2026, Bringing Advanced Thermal Innovation to Mini PCs
- Antengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19 x CD3 TCE) in B Cell-related Autoimmune Diseases
- Best New Meme Coin to Buy: MemeToro Targets Traders Looking Beyond Traditional Memecoin Hype
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share